Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Rethinking What To Call The ‘Real World’
Jul 22 2019
•
By
Sue Sutter
The US FDA may want to rethink the terminology it uses for real-world studies. • Source: Shutterstock
More from Clinical Trials
More from R&D